Eventide Asset Management - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 53 filers reported holding DESIGN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$3,942,000
-39.0%
281,569
-29.6%
0.08%
-16.8%
Q1 2022$6,460,000
-24.6%
400,0000.0%0.10%
-7.3%
Q4 2021$8,564,000
+45.7%
400,0000.0%0.11%
+41.6%
Q3 2021$5,876,000
-26.1%
400,0000.0%0.08%
-28.0%
Q2 2021$7,956,000
-33.5%
400,0000.0%0.11%
-39.5%
Q1 2021$11,960,000400,0000.18%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders